Answers are grounded in this paper and cite their sources.
RRS-82 may be useful for identifying adenocarcinoma patients at very high risk for relapse, even those with cancer in the early stage.
No takes yet. Share an insight, caveat, or question.
Tomida et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: